Emily E. Fink
Cleveland Clinic(US)Kaiser Permanente(US)Charles River Laboratories (Netherlands)(NL)Cleveland Clinic Lerner College of Medicine(US)Charles River Laboratories (Germany)(DE)Charles River Laboratories (United States)(US)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Tissue Engineering and Regenerative Medicine, Bladder and Urothelial Cancer Treatments, Kruppel-like factors research, Genomics and Chromatin Dynamics
Most-Cited Works
- → Nrf2 Amplifies Oxidative Stress via Induction of Klf9(2014)231 cited
- → DNA Methylation Regulates Alternative Polyadenylation via CTCF and the Cohesin Complex(2020)99 cited
- → Oxidative stress and proteasome inhibitors in multiple myeloma(2016)91 cited
- → KLF9 is a novel transcriptional regulator of bortezomib- and LBH589-induced apoptosis in multiple myeloma cells(2011)88 cited
- → Depletion of Deoxyribonucleotide Pools Is an Endogenous Source of DNA Damage in Cells Undergoing Oncogene-Induced Senescence(2012)77 cited
- → KLF9-dependent ROS regulate melanoma progression in stage-specific manner(2019)68 cited